Swaminathan Swarup S, Oh Dong-Jin, Kang Min Hyung, Rhee Douglas J
From Harvard-MIT Division of Health Sciences and Technology (Swaminathan), Harvard Medical School, Boston, Massachusetts, and the Department of Ophthalmology & Visual Sciences (Oh, Kang, Rhee), Case Western Reserve University, Cleveland, Ohio, USA.
From Harvard-MIT Division of Health Sciences and Technology (Swaminathan), Harvard Medical School, Boston, Massachusetts, and the Department of Ophthalmology & Visual Sciences (Oh, Kang, Rhee), Case Western Reserve University, Cleveland, Ohio, USA.
J Cataract Refract Surg. 2014 Aug;40(8):1263-72. doi: 10.1016/j.jcrs.2014.06.020.
The elevated intraocular pressure (IOP) of primary open-angle glaucoma is caused by impaired outflow of aqueous humor through the trabecular meshwork. Within the juxtacanalicular region, alterations of both extracellular matrix homeostasis and the cellular tone of trabecular meshwork endothelial and the inner wall of Schlemm canal cells affect outflow. Newer pharmacologic agents that target trabecular meshwork and Schlemm canal cell cytoskeleton lower IOP. Aqueous drainage occurs nonhomogenously with greater flow going through certain portions of the TM and less going through other portions-a concept known as segmental flow, which is theoretically the result of outflow being dependent on the presence of discrete pores within Schlemm canal. The limited long-term success of trabecular meshwork bypass surgeries implicates the potential impact of resistance in Schlemm canal itself and collector channels. Additionally, others have observed that outflow occurs preferentially near collector channels. These distal structures may be more important to aqueous outflow than previously believed.
Dr. Rhee is a consultant to Aerie Pharmaceuticals, Alcon Laboratories, Inc., Allegan, Inc., Aquesys, Inc., Glaukos Corp., Ivantis, Inc., Johnson & Johnson, Merck Sharp & Dohme Corp. and Santen, Inc., and has received research funding from Alcon Laboratories, Inc., Merck Sharp & Dohme Corp., and Ivantis, Inc. No other author has a financial or proprietary interest in any material or method mentioned.
原发性开角型青光眼的眼压升高是由于房水通过小梁网的流出受损所致。在近小管区域,细胞外基质稳态以及小梁网内皮细胞和施莱姆管内壁细胞的细胞张力的改变都会影响房水流出。靶向小梁网和施莱姆管细胞骨架的新型药物可降低眼压。房水引流并不均匀,通过小梁网某些部分的流量较大,而通过其他部分的流量较小——这一概念称为节段性流动,理论上是由于流出取决于施莱姆管内离散孔隙的存在。小梁网旁路手术长期成功率有限,这暗示了施莱姆管本身和集合管中阻力的潜在影响。此外,其他人观察到房水流出优先发生在集合管附近。这些远端结构对房水流出可能比以前认为的更重要。
Rhee博士是Aerie制药公司、爱尔康实验室公司、艾力根公司、Aquesys公司、Glaukos公司、Ivantis公司、强生公司、默克雪兰诺公司和参天公司的顾问,并已从爱尔康实验室公司、默克雪兰诺公司和Ivantis公司获得研究资金。其他作者对文中提及的任何材料或方法均无财务或专利权益。